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Abstract
In all patients with ST-segment elevation myocardial infarction, risk stratification should be per-
formed before discharge. The measurement of therapy efficiency with magnetic resonance
imaging has been proposed as part of the risk assessment, but it has not been adopted widely.
This meta-analysis was conducted to summarize published data on the prognostic value of the
proportion of salvaged myocardium inside previously ischemic myocardium (myocardial sal-
vage index) measured by T2-weighted and T1-weighted late gadolinium enhancement mag-
netic resonance imaging after ST-segment elevation myocardial infarction. Random and mixed
effects models were used for analyzing the data of 10 studies with 2,697 patients. The pooled
myocardial salvage index, calculated as the proportion of non-necrotic myocardium inside
edematous myocardium measured by T2-weighted and T1-weighted late gadolinium enhance-
ment MRI, was 43.0% (95% confidence interval: 37.4, 48.6). The pooled length of follow-up
was 12.3 months (95% confidence interval: 7.0, 17.6). The pooled incidence of major cardiac
events during follow-up, defined as cardiac death, nonfatal myocardial infarction, or admission
for heart failure, was 10.6% (95% confidence interval: 5.7, 15.5). The applied mixed effects
model showed an absolute decrease of 1.7% in the incidence of major cardiac events during fol-
low-up (95% confidence interval: 1.6, 1.9) with every 1% of increase in the myocardial salvage
index. The heterogeneity between studies was considerable (τ = 21.3). Analysis of aggregated
follow-up data after ST-segment elevation myocardial infarction suggests that the myocardial
salvage index measured by T2-weighted and T1-weighted late gadolinium enhancement mag-
netic resonance imaging provides prognostic information on the risk of major cardiac events,
but considerable heterogeneity exists between studies.
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Introduction
In patients with ST-segment elevation myocardial infarction (STEMI), risk assessment should
be performed early using information available at the time of presentation [1, 2]. The risk strat-
ification should be recalibrated based on information obtained during hospitalization. Patients
having a low risk of complications may be candidates for early discharge. Interventions reduc-
ing the risk of major cardiac events (MACE) should be considered in high-risk patients. The
left ventricular ejection fraction is one of the strongest predictors of survival and should there-
fore be measured in all patients in addition to the assessment of clinical markers of high risk,
including older age, fast heart rate, hypotension, Kilip class > 1, anterior myocardial infarc-
tion, previous myocardial infarction, elevated initial serum creatinine, and history of heart fail-
ure or peripheral arterial disease. Moreover, noninvasive testing for ischemia, such as exercise
testing or pharmacological stress myocardial perfusion, should be performed before discharge
in patients who did not undergo primary percutaneous intervention and may be performed in
patients with non-infarct artery disease who have undergone successful primary percutaneous
intervention of the infarct artery. Several other strategies, including the measurement of ther-
apy efficiency with magnetic resonance imaging (MRI), have been proposed for risk assess-
ment after STEMI; however, these strategies have not been adopted widely, mainly because of
unclear performance characteristics [1, 2].
Therapy efficiency is assessed by MRI through quantification of the salvaged myocardium.
Salvage of ischemic myocardium is the main objective of emergency therapy in STEMI, so the
amount of salvaged myocardium is a valid marker for therapy efficiency [3]. Myocardial sal-
vage is defined as the difference between the previously ischemic myocardium distal to the
infarct artery, the so-called area at risk, and the final necrotic myocardium. To compare the
therapy efficiency among infarcts of different sizes, the myocardial salvage index can be calcu-
lated as the proportion of non-necrotic myocardium inside the area at risk. For assessing the
myocardial salvage index with MRI, T2-weighted MRI and T1-weighted late gadolinium
enhancement MRI have most commonly been combined and used based on the assumptions
that myocardial edema on T2-weighted MRI allows delineating the ischemic area at risk, and
that myocardial necrosis on T1-weighted late gadolinium enhancement MRI can be used to
delineate the final necrotic infarct size [4].
This meta-analysis was performed to summarize published data on the prognostic value of
the myocardial salvage index measured by T2-weighted and T1-weighted late gadolinium
enhancement MRI after STEMI.
Materials and methods
We reported this meta-analysis according to the PRISMA guidelines [5].
Eligibility criteria
The following inclusion criteria were applied: a) diagnosis of STEMI in the study patients; b)
primary percutaneous intervention as emergency therapy; c) MRI in week 1 after STEMI with
reporting of the myocardial salvage index measured by T2-weighted and T1-weighted late gad-
olinium enhancement MRI or, alternatively, the spatial extent of edematous left ventricular
myocardium measured by T2-weighted MRI along with the spatial extent of left ventricular
necrotic myocardium measured by T1-weighted late gadolinium enhancement MRI, so that it
was possible to calculate the myocardial salvage index; d) usage of a volumetric unit compati-
ble to the percentage of left ventricular myocardium for the measurement of edema and necro-
sis with MRI; e) reporting of the standard deviation, interquartile range, or confidence interval
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(CI) for the myocardial salvage index or the spatial extents of edema and necrosis measured by
T2-weighted and T1-weighted late gadolinium enhancement MRI; f) follow-up assessment of
MACE defined as cardiac death, nonfatal myocardial infarction, or admission for heart failure;
and g) English, French, or German as publication language. We excluded animal studies.
The eligibility criteria were determined by the two reviewers and discussed in the research
group on noninvasive cardiovascular imaging at Charite´–Universita¨tsmedizin Berlin.
Search strategy
We searched in the electronic databases MEDLINE (via PubMed), EMBASE (via Ovid), and
ISI Web of Science for references published between the inception of the databases and May
15, 2019. We used a search term that was adjusted according to the standards of the respective
databases. The full adjusted search terms can be found in S1 Appendix A. The titles and
abstracts of references revealed by the database search were screened, and a full-text review of
remaining articles was performed. Additionally, we searched in the bibliographies of finally
included studies and reviews revealed by the database search for studies that were missed by
the database search.
The search term was determined by the two reviewers and discussed in the research group
on noninvasive cardiovascular imaging at Charite´–Universita¨tsmedizin Berlin. The search in
the databases, the title and abstract review, and the full-text review were performed by one
reviewer (BK); ambiguities were resolved by discussion with the second reviewer (MD).
Data extraction
A datasheet was predefined, and the following information was extracted from every included
study: a) title, first author, publishing journal, and year of publication; b) purpose of the study
as mentioned by the study authors; c) study design; d) number of included patients in every
patient group; e) myocardial salvage index measured by T2-weighted and T1-weighted late
gadolinium enhancement MRI or both the spatial extent of edematous left ventricular myocar-
dium measured by T2-weighted MRI and the spatial extent of left ventricular necrotic myocar-
dium measured by T1-weighted late gadolinium enhancement MRI so that the myocardial
salvage index could be calculated; f) incidence of MACE during follow-up; and g) length of fol-
low-up.
The datasheet was created by the two reviewers and discussed in the working group on non-
invasive cardiovascular imaging at Charite´–Universita¨tsmedizin Berlin. Data extraction was
performed by one reviewer (BK); ambiguities were resolved by discussion with the second
reviewer (MD).
Statistical analysis
The myocardial salvage index was calculated as the proportion of non-necrotic myocardium
inside edematous myocardium if the studies did not state the myocardial salvage index mea-
sured by T2-weighted and T1-weighted late gadolinium enhancement MRI but provided the
spatial extent of edematous left ventricular myocardium measured by T2-weighed MRI and
the spatial extent of necrotic left ventricular myocardium measured by T1-weighted late gado-
linium enhancement MRI.
Random effects models were used to calculate pooled values for the extracted clinical char-
acteristics of the included study populations (age, gender, prevalence of diabetes, prevalence of
hypertension, current smoking, and left ventricular ejection fraction), the time period between
STEMI and MRI, the myocardial salvage index measured by T2-weighted and T1-weighted
late gadolinium enhancement MRI, the length of follow-up, and the incidence of MACE
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during follow-up. Study was included as random effect in all random effects models to account
for multiple observations per study. To evaluate the difference in the incidence of MACE
between studies with a follow-up length of less than 12 months and studies with a follow-up
length equal to or more than 12 months, we added the follow-up length as a categorical vari-
able to the random effects model on the incidence of MACE during follow-up.
Afterwards, we evaluated whether a patient group’s mean myocardial salvage index mea-
sured by T2-weighted and T1-weighted late gadolinium enhancement MRI correlated with the
incidence of MACE in this patient group during follow-up using a mixed effects model. The
incidence of MACE during follow-up was used as the dependent variable. The myocardial sal-
vage index was included as fixed effect. To correct for differences in the follow-up period, we
included the centered length of follow-up as another fixed effect. Study was included as ran-
dom effect, again to account for multiple observations per study, which was evaluated by
applying Cochran’s Q test. On request of the reviewers, we performed a heterogeneity analysis.
We suspected that a part of the between-study-heterogeneity could be explained by differences
in the average cardiovascular risk of the study populations and the used MRI technique. We
therefore included two main cardiovascular risk factors (mean age and prevalence of diabetes)
and two main MRI technique parameters (timing of MRI and MRI interpretation) in the
mixed effects model and compared the heterogeneity with that of the previous mixed effects
model without the inclusion of these factors.
Each patient group’s result was weighted by the inverse of the squared estimated standard
error of the mean of the myocardial salvage index. Statistical significance was assumed for p-
values of 0.05 or smaller. We used R (version 3.6.0, 2019, R Foundation of Statistical Comput-
ing) for all calculations. Random and mixed effects models were generated using the metafor
R package [6].
Statistics were planned in the research group on noninvasive cardiovascular imaging at
Charite´–Universita¨tsmedizin Berlin. Statistical analysis was performed by one reviewer (BK),
and the results were discussed in the research group.
Risk of bias assessment
As we included studies with different study designs, we applied different quality assessment
tools. According to a systematic review by Zeng et al. [7], the Cochrane Risk of Bias Tool [8]
was used for randomized controlled trials, the Newcastle Ottawa Quality Assessment Scale [9]
was used for nonrandomized cohort studies and case control studies, and an 18-item tool by
Moga et al. [10] was used for case series studies. To test for the risk of publication bias across
studies, Begg and Mazumdar’s rank correlation test with continuity correction and Egger’s
regression test were used in the data on the myocardial salvage index in addition to visually
inspecting a funnel plot for obvious asymmetry.
The risk of bias assessment was planned by the two reviewers. Application of the tools was
done by one reviewer (BK); ambiguities were resolved by discussion with the second reviewer
(MD).
Results
The search in the electronic databases revealed 1625 references. After removal of duplicates,
we screened 1191 references for eligible studies. We excluded 1,019 records at the level of title
and abstract. Another 163 references were excluded after the full-text review: 22 because the
study patients did not have a STEMI diagnosis, 102 because T2-weighted and late gadolinium
enhancement MRI was not done or not sufficiently reported to extract the myocardial salvage
index, 38 because follow-up assessment of the incidence of MACE, defined as cardiac death,
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nonfatal myocardial infarction, or admission for heart failure, was not performed, and one
study because of the language of publication. One eligibly study was found by searching the
bibliographies of the included studies and reviews revealed by the database search. Thus, we
finally included 10 studies [11–20] with a total of 2,697 patients: two randomized controlled
trials [14, 15], six nonrandomized cohort studies [11, 13, 16–19], one case control study [12],
and one case series study [20]. Fig 1 shows the PRISMA flow chart [5] summarizing the selec-
tion process. The extracted clinical characteristics of the study populations and the used MRI
technique is summarized in Table 1.
The random effects models revealed a pooled myocardial salvage index measured by
T2-weighted and T1-weighted late gadolinium enhancement MRI of 43.0% (95% confidence
interval: 37.4, 48.6), a pooled length of follow-up of 12.3 months (95% CI: 7.0, 17.6), and a
pooled incidence of MACE during follow-up of 10.6% (95% CI: 5.7, 15.5). Fig 2 shows the
mean myocardial salvage index for all patient groups sorted by the incidence of MACE during
follow-up in a forest plot.
The mixed effects model showed a negative correlation between a patient group’s mean
myocardial salvage index measured by T2-weighted and T1-weighted late gadolinium
enhancement MRI and the incidence of MACE in this patient group during follow-up. There
was an absolute decrease of 1.7% in the incidence of MACE during follow-up (95% CI: 1.6,
1.9) with every 1% of increase in the myocardial salvage index measured by T2-weighted and
T1-weighted late gadolinium enhancement MRI. The heterogeneity between studies was con-
siderable (τ = 21.3). Model details can be found in Table 2.
The inclusion of two main cardiovascular risk factors (mean age and prevalence of diabetes)
and two main MRI technique parameters (timing of MRI and MRI interpretation) in the
model for the exploration of heterogeneity reduced the unexplained standard deviation
between studies by 65.3% to τ = 7.4. The details of this adjusted model can be found in S4
Table.
The results of the risk of bias assessment in individual studies are summarized in S2 Table.
In one study [12], the quality is reduced by the retrospective design and the uncertainty
whether the dropouts were similarly distributed in the within-study groups. In four other stud-
ies [11, 15, 16, 19], the quality is reduced by a short follow-up length of 6 months. We did not
find evidence of publication bias across studies in the data on the myocardial salvage index
measured by T2-weighted and T1-weighted late gadolinium enhancement MRI after STEMI
by applying Begg and Mazumdar’s rank correlation test (z = -1.67, P = 0.097) and Egger’s
regression test (t = -1.17, P = 0.255) as well as by visually inspecting the created funnel plot for
obvious asymmetry (S1 Fig).
Discussion
This study was conducted to summarize published data on the prognostic value of the myocar-
dial salvage index measured by T2-weighted and T1-weighted late gadolinium enhancement
MRI after STEMI. Meta-regression analysis of aggregated published data shows that a high
myocardial salvage index measured by T2-weighted and T1-weighted late gadolinium
enhancement MRI in week 1 after STEMI is associated with a low incidence of MACE during
follow-up and vice versa with considerable heterogeneity between studies.
To the best of our knowledge, no previous meta-analysis has summarized published data
on the prognostic value of the myocardial salvage index measured by T2-weighted and
T1-weighted late gadolinium enhancement MRI after STEMI. Two clinical studies, which are
included in this meta-analysis, compared the myocardial salvage index measured by
T2-weighted and T1-weighted late gadolinium enhancement MRI between patients with and
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PLOS ONE | https://doi.org/10.1371/journal.pone.0228736 February 13, 2020 5 / 12
Fig 1. PRISMA flow chart. The search in the electronic databases revealed 1,625 references. A full-text review of 173 studies was performed. Ten studies were
found to be eligible and were included in this meta-analysis. STEMI: ST-segment elevation myocardial infarction. MRI: magnetic resonance imaging, SD: standard
deviation, IQR: interquartile range, CI: confidence interval, MACE: major cardiac events.
https://doi.org/10.1371/journal.pone.0228736.g001
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Table 1. Clinical characteristics of the study populations and the used MRI technique.
Clinical characteristics of the study populations Pooled mean (95%
CI)
Age, years 60.5 (95% CI: 58.4,
62.5)
Male, % of patients 80.3 (95% CI: 76.7,
84.0)
Diabetes, % of patients 22.7 (95% CI: 20.9,
24.7)
Hypertension, % of patients 51.7 (95% CI: 42.3,
61.2)
Dyslipidemia, % of patients 32.0 (95% CI: 24.8,
39.3)
Current smoking, % of patients 50.5 (95% CI: 43.5,
57.5)
Left ventricular ejection fraction, % 51.4 (95% CI: 49.3,
53.5)
MRI technique used in the studies Pooled mean (95%
CI)
Timing of MRI, days after STEMI 4.6 (95% CI: 3.2, 6.0)
T2-weighted MRI sequencea
T2-weighted dark-blood TSE/FSE with IR (STIR) 10 studies (2,697
patients)
T1-weighted late gadolinium enhancement MRI sequenceb
IR or PSIR using segmented FLASH readout (SPGR) 9 studies (2,393
patients)
IR with single-shot SSFP 1 study (304 patients)
MRI interpretationc
Signal intensity> 2 SD above remote myocardium for delineating myocardial edema on
T2-weighted MRI and > 5 SD above remote myocardium for quantifying myocardial
necrosis on T1-weighted late gadolinium enhancement MRI
6 studies (1,970
patients)
Manual contouring for both delineating myocardial edema on T2-weighted MRI and
quantifying myocardial necrosis on T1-weighted late gadolinium enhancement MRI
4 studies (727
patients)
Type of gadolinium contrast agent
Gadobutrol 4 studies (1,404
patients)
Gadopentetate 3 studies (700
patients)
Gadoterate 2 studies (247
patients)
Gadobutrol or gadopentetate 1 study (346 patients)
Dose of gadolinium contrast agent
0.15 mmol/kg 5 studies (1,522
patients)
0.2 mmol/kg 4 studies (871
patients)
(Continued)
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without occurrence of MACE during follow-up. Eitel et al. and de Waha et al. found a signifi-
cant difference in the myocardial salvage index between patients with and without MACE dur-
ing follow-up [12, 14]. De Waha et al. additionally identified the myocardial salvage index as
an independent predictor for the incidence of MACE after adjusting for all traditional out-
come parameters [12].
As stated in the introduction, the current American College of Cardiology/American Heart
Association guideline for STEMI and the current European Society of Cardiology guideline
for STEMI recommend risk stratification in all patients hospitalized for STEMI. As a part of
the risk assessment, the resting left ventricular ejection fraction should always be measured
before discharge, as it is one of the strongest prognostic predictors [1, 2]. Measurement of the
resting left ventricular ejection fraction and valve function along with left ventricular throm-
bus assessment is most commonly performed by echocardiography [21]; however, cardiac cine
MRI sequences can also be applied for this purpose [22]. The combination of cine sequences
with T2-weighted and T1-weighted late gadolinium enhancement MRI may be used to assess
the left ventricular ejection fraction, valve function, existence of a left ventricular thrombus,
and the myocardial salvage index as additional prognostic parameter in one examination.
Whether additional routine assessment of the myocardial salvage index using cardiac MRI
improves the long-term outcome in STEMI patients by more effectively identifying patients
who need intensified support or interventions could be studied in a randomized controlled
trial.
This meta-analysis has limitations. First, a review protocol was not registered a priori, and
so the likelihood that our post hoc decisions are biased is increased [5]. Second, one reviewer
conducted the systematic search in the electronic databases, the data extraction, statistical anal-
ysis, and risk of bias assessment. This resulted in a higher likelihood of errors in these pro-
cesses [5, 23]. Third, whether myocardial edema measured by T2-weighted MRI accurately
delineates the previously ischemic area at risk is a controversial discussion; thus, whether the
myocardial salvage index measured by T2-weighted and T1-weighted late gadolinium
enhancement MRI provides an exact measure of the proportion of salvaged myocardium
inside the previously ischemic area at risk is unclear [24]. Fourth, we decided against excluding
study designs from our analysis, which increases the risk of bias in the analysis; however, we
did not find publication bias in the data. Last, the statistical analysis revealed considerable
Table 1. (Continued)
0.1 mmol/kg 1 study (304 patients)
MRI: magnetic resonance imaging, STEMI: ST-segment elevation myocardial infarction, MACE: major cardiac
events, SD: standard deviation, TSE: turbo spin echo, FSE: fast spin echo, IR: inversion recovery, STIR: short tau
inversion recovery, SSFP: steady state free precession, ACUTE: Acquisition for Cardiac Unified T2 Edema, PSIR:
phase sensitive inversion recovery, FLASH: fast low angle shot, SPGR: spoiled gradient echo, MD: magnetization
driven, FWHM: full width at half maximum, OAT: Otsu’s Automated Technique, FACT: automated feature analysis
and combined thresholding infarct sizing.
aCategories: T2-weighted dark-blood TSE/FSE with IR (STIR), T2-prepared bright-blood single-shot balanced SSFP,
hybrid TSE-SSFP (ACUTE), BLADE k-space coverage for dark-blood TSE.
bCategories: IR or PSIR using segmented FLASH readout (also referred to as SPGR), IR or PSIR with single-shot
SSFP, MD steady state FLASH.
CCategories: signal intensity > 2 SD above remote myocardium, signal intensity > 3 SD above remote myocardium,
signal intensity > 5 SD above remote myocardium, manual threshold, FWHM algorithm, manual contouring, OAT,
FACT algorithm, Heiberg’s method.
https://doi.org/10.1371/journal.pone.0228736.t001
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heterogeneity between the included studies. Therefore, exact thresholds of the myocardial sal-
vage index for a low or high risk of MACE cannot be provided.
As a large part of the between-study heterogeneity could be reduced by including cardiovas-
cular risk factors and MRI technique parameters in the meta-regression model, the myocardial
salvage index should be interpreted in conjunction with cardiovascular risk factors and the
used MRI technique when applied for prognostic purposes. T2- and T1-weighted mapping
MRI, as a relatively new and increasingly used alternative to conventional T2-weighted and
Fig 2. Forest plot. Mean myocardial salvage index, length of follow-up, and the incidence of MACE during follow-up for all patient groups. MACE: major cardiac
events.
https://doi.org/10.1371/journal.pone.0228736.g002
Table 2. Model parameters of the mixed effects model.
Dependent variable
Incidence of MACE during follow up, % of patients
Random effects
Factor τ2 τ Cochran’s Q test for heterogeneity
p
study 452.32 21.27 < 0.001
Fixed effects
Factor Estimate p Lower 95% CI Upper 95%CI
(Intercept) 84.56 < 0.001 70.24 98.88
Myocardial salvage index, % -1.73 < 0.001 -1.85 -1.60
Centered length of follow-up, monthsa 0.42 0.593 -1.13 1.98
MACE: major cardiac events, CI: confidence interval.
aThe centered length of follow-up was included into the model to correct for differences in the follow-up length among studies. There was a 9.5% difference in the
incidence of MACE during follow-up (95% CI: 1.2, 17.8; P = 0.024) between studies with a follow-up length of less than 12 months and studies with a follow-up length
equal to or more than 12 months.
https://doi.org/10.1371/journal.pone.0228736.t002
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T1-weighted late gadolinium enhancement MRI, allows a more consistent and less subjective
delineation of edematous and fibrotic myocardium and may therefore reduce heterogeneity
induced by differences in the used MRI technique between study sites in the future [25]. We
decided to search for studies that measured myocardial oedema and necrosis with conven-
tional T2-weighted and T1-weighted late gadolinium enhancement MRI, as only a few studies
have applied mapping MRI for measuring the myocardial salvage index so far, and we were
aiming to include enough data for a valid meta-regression analysis.
In conclusion, analysis of aggregated follow-up data after STEMI suggests that the myocar-
dial salvage index measured by T2-weighted and T1-weighted late gadolinium enhancement
MRI provides prognostic information on the risk of MACE, but considerable heterogeneity
exists between studies.
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